Frequency of Early Refills for Opioids in the United States.


Journal

Pain medicine (Malden, Mass.)
ISSN: 1526-4637
Titre abrégé: Pain Med
Pays: England
ID NLM: 100894201

Informations de publication

Date de publication:
01 09 2020
Historique:
pubmed: 13 6 2020
medline: 15 5 2021
entrez: 13 6 2020
Statut: ppublish

Résumé

Refilling an opioid prescription early is an important risk factor of prescription opioid abuse and misuse; we aimed to understand the scope of this behavior. This study was conducted to quantify the prevalence and distribution of early refills among patients prescribed opioids. We conducted a retrospective cohort study utilizing dispensed prescription records. Patients filling one or more prescription opioids were identified and followed for one year. Early refills were defined as having a second prescription filled ≥15% early relative to the days' supply of the previous prescription for the same opioid (according to the National Drug Code [NDC]). The distribution of the number of early refills and patient characteristics were assessed. A total of 60.6 million patients met the study criteria; 28.8% had two or more opioid prescriptions for the same opioid during follow-up. Less than 3% of all patients receiving an opioid had an early refill. Approximately 10% of those with two or more opioid prescriptions for the same drug had an early refill. For patients with multiple fills (N = 1.5 million with extended-release long-acting [ER/LA] opioids; N = 17.1 million with immediate-release short-acting [IR/SA] opioids), early refills were more common among patients with an ER/LA opioid (18.5%) compared with an IR/SA opioid (8.7%). Three-quarters of patients with an early refill had only one (70.9% and 78.4% for ER/LA and IR/SA, respectively). Refilling an opioid prescription with the same opioid early is an infrequent behavior within all opioid users, but more common in ER/LA users. Patients who refilled early tended to do so just once.

Identifiants

pubmed: 32529224
pii: 5856230
doi: 10.1093/pm/pnaa161
pmc: PMC7553021
doi:

Substances chimiques

Analgesics, Opioid 0
Delayed-Action Preparations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1818-1824

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine.

Références

MMWR Surveill Summ. 2015 Oct 16;64(9):1-14
pubmed: 26469747
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
MMWR Morb Mortal Wkly Rep. 2017 Jul 07;66(26):697-704
pubmed: 28683056
NCHS Data Brief. 2018 Nov;(329):1-8
pubmed: 30500323
Am J Manag Care. 2009 Dec;15(12):897-906
pubmed: 20001171
Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):115-23
pubmed: 20014166
N Engl J Med. 2015 Jan 15;372(3):241-8
pubmed: 25587948
Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):36-43
pubmed: 19040199
CNS Drugs. 2010 Jul;24(7):611-20
pubmed: 20527997
J Gen Intern Med. 2011 Sep;26(9):958-64
pubmed: 21347877

Auteurs

David M Kern (DM)

Janssen Research & Development, LLC, Titusville, New Jersey.

M Soledad Cepeda (MS)

Janssen Research & Development, LLC, Titusville, New Jersey.

Maribel Salas (M)

Daiichi-Sankyo, Clinical Safety and Pharmacovigilance, and Epidemiology, Basking Ridge, New Jersey.
University of Pennsylvania Perelman School of Medicine, CCEB/CPeRT, Philadelphia, Pennsylvania.

Syd Phillips (S)

IQVIA Epidemiology & Drug Safety, Seattle, Washington.

Matthew H Secrest (MH)

IQVIA Epidemiology & Drug Safety, Cambridge, Massachusetts.

Gregory P Wedin (GP)

Upsher-Smith Laboratories, LLC, Pharmacovigilance & Risk Management, Maple Grove, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH